Immediate Impact

1 by Nobel laureates 1 from Science/Nature 50 standout
Sub-graph 1 of 23

Citing Papers

Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Age-Related Macular Degeneration
2024 Standout
1 intermediate paper

Works of Jason B. Litten being referenced

Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors
2014
Pharmacovigilance and biosimilars: considerations, needs and challenges
2013

Author Peers

Author Last Decade Papers Cites
Jason B. Litten 131 201 99 125 21 522
Leung Li 201 130 139 37 33 540
Philippe Rochigneux 388 95 42 155 39 625
Lisa A. Raedler 282 174 47 141 24 591
Oyewale O. Abidoye 447 142 62 101 24 648
Thomas A. Samuel 159 235 28 103 29 550
Justyna Amelio 142 90 28 70 20 459
Jie Zhang 189 119 32 76 26 512
Patrick Thompson 187 288 63 26 25 620
Lois Dickie 222 104 195 25 13 603
Jeffrey Patton 201 93 32 50 27 506

All Works

Loading papers...

Rankless by CCL
2026